secwatch.observer — SEC 8-K summary
======================================

Issuer:     Jaguar Health, Inc. (JAGX)
CIK:        0001585608
Form:       8-K
Filed at:   2026-06-11T13:00:07+00:00
Accession:  0001193125-26-266770
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 3.02, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Jaguar Health secures up to $40M equity line and $2M preferred stock financing
------------------------------------------------------------------------------

- ELOC agreement provides up to $40M of common stock purchases; floor price set at $1.10 per share.
- Single fixed purchase capped at $1.5M; $800K commitment shares to be issued upon registration effectiveness.
- Series P preferred stock financing: 240 shares at $10K stated value, 8% annual dividend, mandatory redemption with ELOC proceeds.
- Stockholder approval obtained June 8, 2026 allowing issuances beyond 19.99% for both facilities.
- Proceeds intended for general corporate purposes; registration statements to be filed within 30 days.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1585608/000119312526266770/0001193125-26-266770-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1585608/000119312526266770/d570985d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-266770

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer